American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA; 2013.

Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, et al. The world Federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789–818.

Article  PubMed  PubMed Central  Google Scholar 

Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics. 2012;9(3):490–9.

Article  PubMed Central  Google Scholar 

Arnold LE, Hodgkins P, Kahle J, Madhoo M, Kewley G. Long-term outcomes of ADHD: academic achievement and performance. J Atten Disord. 2020;24(1):73–85.

Article  PubMed  Google Scholar 

Craig F, Savino R, Fanizza I, Lucarelli E, Russo L, Trabacca A. A systematic review of coping strategies in parents of children with attention deficit hyperactivity disorder (ADHD). Res Dev Disabil. 2020;98:103571.

Article  PubMed  Google Scholar 

McQuade JD, Breaux R, Mordy AE, Taubin D. Childhood ADHD symptoms, parent emotion socialization, and adolescent peer problems: indirect effects through emotion dysregulation. J Youth Adolesc. 2021;50(12):2519–32.

Article  PubMed  Google Scholar 

Powell V, Riglin L, Hammerton G, Eyre O, Martin J, Anney R, et al. What explains the link between childhood ADHD and adolescent depression? Investigating the role of peer relationships and academic attainment. Eur Child Adolesc Psychiatry. 2020;29(11):1581–91.

Article  PubMed  PubMed Central  Google Scholar 

Sigfusdottir ID, Asgeirsdottir BB, Hall HA, Sigurdsson JF, Young S, Gudjonsson GH. An epidemiological study of ADHD and conduct disorder: does family conflict moderate the association? Soc Psychiatry Psychiatr Epidemiol. 2017;52(4):457–64.

Article  PubMed  Google Scholar 

Sharp W, Mangalmurti A, Hall C, Choudhury S, Shaw P. Associations between neighborhood, family factors and symptom change in childhood attention deficit hyperactivity disorder. Soc Sci Med. 2021;271:112203.

Article  PubMed  Google Scholar 

Tung I, Li JJ, Meza JI, Jezior KL, Kianmahd JSV, Hentschel PG, et al. Patterns of comorbidity among girls with ADHD: a Meta-analysis. Pediatrics. 2016;138(4):e20160430.

Article  PubMed  Google Scholar 

Reale L, Bartoli B, Cartabia M, Zanetti M, Costantino MA, Canevini MP, et al. Comorbidity prevalence and treatment outcome in children and adolescents with ADHD. Eur Child Adolesc Psychiatry. 2017;26(12):1443–57.

Article  PubMed  Google Scholar 

Zenglein Y, Schwenck C, Westerwald E, Schmidt C, Beuth S, Meyer J, et al. Empirically determined, psychopathological subtypes in children with ADHD. J Atten Disord. 2016;20(2):96–107.

Article  PubMed  Google Scholar 

Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40(2):147–58.

Article  CAS  PubMed  Google Scholar 

Reale L, Bonati M. ADHD prevalence estimates in Italian children and adolescents: a methodological issue. Ital. J Pediatr. 2018;44(1):108.

Google Scholar 

Società Italiana di Neuropsichiatria dell’Infanzia e dell’Adolescenza. Linee-guida per la diagnosi e la terapia farmacologica del Disturbo da Deficit Attentivo con Iperattività (ADHD) in età evolutiva. Approvazione CD. 24 giugno 2002 [Internet]. 2002 [citato 22 aprile 2022]. Disponibile su: http://sinpia.eu/linee-guida-3/.

Agenzia Italiana del Farmaco. Protocollo diagnostico e terapeutico della sindrome di iperattivita e deficit di attenzione per il registro nazionale ADHD (all. 1 - art. 1). Gazzetta Ufficiale Serie Generale n.95 del 24-04-2007 - Suppl. Ordinario N. 2007;106.

Panei P, Arcieri R, Vella S, Bonati M, Martini N, Zuddas A. Italian attention-deficit/hyperactivity disorder registry. Pediatrics. 2004;114(2):514.

Article  PubMed  Google Scholar 

Panei P, Kneiiwoif AL, Bonati M, Masi G, Zuddas A, Costantino A, et al. Psychotropic Drug Used for Attention-Deficit/Hyperactivity Disorder (ADHD) in Italian Children and Adolescent Population. Drug-Saf. 2008;31(10):885–885.

Google Scholar 

Panei P, Arcieri R, Bonati M, Bugarini M, Didoni A, Germinario E. Safety of psychotropic drug prescribed for attention-deficit/hyperactivity disorder in Italy. Adverse Drug React Bull. 2010;260:999–1002.

Article  Google Scholar 

Conrad P, Bergey MR. The impending globalization of ADHD: notes on the expansion and growth of a medicalized disorder. Soc Sci Med. 2014;122:31–43.

Article  PubMed  Google Scholar 

Maschietto D, Baioni E, Vio C, Novello F, Germinario E, Regini F, et al. Prevalenza dell’ADHD in una popolazione pediatrica e sua esposizione al trattamento psico–comportamentale e farmacologico. Medico e Bambino. 2012;XV(10):667.

Google Scholar 

Panei P, Arcieri R. Il registro dell’ADHD: valutazione post-marketing del profilo beneficio-rischio dei farmaci e promozione dell’appropriatezza. Recenti Progressi Med.. 2013;104(6):254–261.

Reale L, Zanetti M, Cartabia M, Fortinguerra F, Bonati M, Adhd a nome GRL. Due anni di attività del Registro ADHD della Regione Lombardia: analisi dei percorsi di cura diagnostici e terapeutici. Ricerca Pratica. 2014;30(5):198–211.

Google Scholar 

Bonati M, Reale L, Zanetti M, Cartabia M, Fortinguerra F, Capovilla G, et al. A regional ADHD center-based network project for the diagnosis and treatment of children and adolescents with ADHD. J Atten Disord. 2018;22(12):1173–84.

Article  PubMed  Google Scholar 

Bonati M, Scarpellini F, Cartabia M, Zanetti M, on behalf of the Lombardy ADHD Group. Ten years (2011–2021) of the Italian Lombardy ADHD register for the diagnosis and treatment of children and adolescents with ADHD. Children. 2021;8(7):598.

Article  PubMed  PubMed Central  Google Scholar 

Atzori P, Usala T, Carucci S, Danjou F, Zuddas A. Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study. J Child Adolesc Psychopharmacol. 2009;19(6):673–81.

Article  PubMed  Google Scholar 

Ahmed R, Aslani P. Attention-deficit/hyperactivity disorder: an update on medication adherence and persistence in children, adolescents and adults. Expert Rev Pharmacoecon Outcomes Res. 2013;13(6):791–815.

Article  PubMed  Google Scholar 

Bhang SY, Hwang JW, Kwak YS, Joung YS, Lee S, Kim B, et al. Differences in utilization patterns among medications in children and adolescents with attention-deficit/hyperactivity disorder: a 36-month retrospective study using the Korean health insurance review and assessment claims database. J Korean Med Sci. 2016;31(8):1284–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lachaine J, Beauchemin C, Sasane R, Hodgkins PS. Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective. Postgrad Med Maggio. 2012;124(3):139–48.

Article  Google Scholar 

Catalá-López F, Hutton B, Núñez-Beltrán A, Page MJ, Ridao M, Macías Saint-Gerons D, et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials. PLoS One. 2017;12(7):e0180355.

Article  PubMed  PubMed Central  Google Scholar 

Frank E, Ozon C, Nair V, Othee K. Examining why patients with attention-deficit/hyperactivity disorder lack adherence to medication over the long term: a review and analysis. J Clin Psychiatry. 2015;76(11):e1459–68.

Article  PubMed  Google Scholar 

Gajria K, Lu M, Sikirica V, Greven P, Zhong Y, Qin P, et al. Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder - a systematic literature review. Neuropsychiatr Dis Treat. 2014;10:1543–69.

PubMed  PubMed Central  Google Scholar 

Gau SSF, Chen SJ, Chou WJ, Cheng H, Tang CS, Chang HL, et al. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J Clin Psychiatry. 2008;69(1):131–40.

Article  CAS  PubMed  Google Scholar 

Khan MU, Aslani P. A review of factors influencing the three phases of medication adherence in people with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2019;29(6):398–418.

Article  PubMed  Google Scholar 

Palli SR, Kamble PS, Chen H, Aparasu RR. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2012;22(2):139–48.

Article  CAS  PubMed  Google Scholar 

Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane Database Syst Rev. 2018;5:CD012069.

PubMed  Google Scholar 

Wang LJ, Yang KC, Lee SY, Yang CJ, Huang TS, Lee TL, et al. Initiation and persistence of pharmacotherapy for youths with attention deficit hyperactivity disorder in Taiwan. PLoS One. 2016;11(8):e0161061.

Article  PubMed  PubMed Central  Google Scholar 

Wong ICK, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, et al. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. Health Technol Assess. 2009;13(50):1–120 iii–iv, ix–xi.

Google Scholar 

Bhang SY, Kwack YS, Joung YS, Lee SI, Kim B, Sohn SH, et al. Factors that affect the adherence to ADHD medications during a treatment continuation period in children and adolescents: a Nationwide retrospective cohort study using Korean health insurance data from 2007 to 2011. Psychiatry Investig. 2017;14(2):158–65.

Article  PubMed  PubMed Central  Google Scholar 

Safavi P, Saberzadeh M, Tehrani AM. Factors associated with treatment adherence in children with attention deficit hyperactivity disorder. Indian J Psychol Med. 2019;41(3):252–7.

Article  PubMed  PubMed Central  Google Scholar 

Nayak AS, Nachane HB, Keshari P, Parkar SR, Saurabh KH, Arora M. Prescription patterns and medication adherence in preadolescent children with attention deficit hyperactivity disorder. Indian J Psychiatry. 2021;63(3):274–8.

Article  PubMed  PubMed Central  Google Scholar 

Ishizuya A, Enomoto M, Tachimori H, Takahashi H, Sugihara G, Kitamura S, et al. Risk factors for low adherence to methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder. Sci Rep. 2021;11(1):1707.

Article  CAS  PubMed  PubMed Central  Google Scholar